Related Experiment Video
Updated: Jun 28, 2026
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Aortic balloon valvuloplasty--review and case series
Richard J Jabbour1, Ron Dick, Anthony S Walton
1Epworth Hospital, Level 6, 89 Bridge Road, Richmond 3121, Victoria, Australia.
Heart, Lung & Circulation
|November 18, 2008
Summary
Aortic balloon valvuloplasty (BAV) was an early alternative to surgery for aortic stenosis but showed high restenosis rates and complications. This review covers management for severe aortic stenosis patients unfit for surgery.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Background:
- Aortic balloon valvuloplasty (BAV) emerged in the 1980s as a less invasive option for aortic stenosis treatment.
- The initial aim was to reduce complications compared to surgical aortic valve replacement.
Observation:
- BAV demonstrated a higher complication rate than anticipated.
- Hemodynamic improvements were modest, and restenosis rates were unacceptably high.
- Consequently, BAV has been largely abandoned in clinical practice.
Findings:
- The procedure's efficacy as a surgical substitute is limited due to poor long-term outcomes.
- Restenosis remains a significant challenge, diminishing the procedure's durability.
- BAV's initial promise has not translated into widespread clinical acceptance.
Implications:
- This review focuses on managing severe aortic stenosis in patients unsuitable for surgery.
- Alternative strategies and palliative care may be necessary for this patient group.
- Further research into less invasive, more durable treatments is warranted.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...